Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging Agent.
AAPS J. 2020 Jan 3;22(2):22. doi: 10.1208/s12248-019-0392-0.
AAPS J. 2020.
PMID: 31900688
Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities.
Wang X, Phan MM, Li J, Gill H, Williams S, Gupta N, Quarmby V, Yang J.
Wang X, et al. Among authors: phan mm.
Antibodies (Basel). 2020 Mar 25;9(2):7. doi: 10.3390/antib9020007.
Antibodies (Basel). 2020.
PMID: 32218192
Free PMC article.
Item in Clipboard
Development of an SPR-based binding assay for characterization of anti-CD20 antibodies to CD20 expressed on extracellular vesicles.
Wang X, Phan MM, Sun Y, Koerber JT, Ho H, Chen Y, Yang J.
Wang X, et al. Among authors: phan mm.
Anal Biochem. 2022 Jun 1;646:114635. doi: 10.1016/j.ab.2022.114635. Epub 2022 Mar 10.
Anal Biochem. 2022.
PMID: 35278435
Free article.
Item in Clipboard
Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.
Ogasawara A, Kiefer JR, Gill H, Chiang E, Sriraman S, Ferl GZ, Ziai J, Bohorquez SS, Guelman S, Wang X, Yang J, Phan MM, Nguyen V, Chung S, Yu C, Tinianow J, Waaijer SJH, De Crespigny A, Marik J, Boswell CA, Zabka T, Staflin K, Williams SP.
Ogasawara A, et al. Among authors: phan mm.
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):287-301. doi: 10.1007/s00259-022-05968-6. Epub 2022 Oct 22.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36271158
Item in Clipboard
Correction to: Preclinical development of ZED8, an 89Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.
Ogasawara A, Kiefer JR, Gill H, Chiang E, Sriraman S, Ferl GZ, Ziai J, Bohorquez SS, Guelman S, Wang X, Yang J, Phan MM, Nguyen V, Chung S, Yu C, Tinianow J, Waaijer SJH, De Crespigny A, Marik J, Boswell CA, Zabka T, Staflin K, Williams SP.
Ogasawara A, et al. Among authors: phan mm.
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):631. doi: 10.1007/s00259-022-06050-x.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36427067
No abstract available.
Item in Clipboard
Cite
Cite